Shattuck Labs, Inc. Common Stock (STTK) Stock
NASDAQ · STTK
6.01
Fundamentals
Market cap
$603.18M
Price / Earnings ratio
-11.2x
Price / Sales ratio
587.1x
Price / Book ratio
2.8x
Return on assets
-0.6%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Shattuck Labs, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees40
CEODr. Taylor H. Schreiber M.D., Ph.D.
IPO DateOct 9, 2020
HeadquartersAustin, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Taylor H. Schreiber M.D., Ph.D. | Co-Founder, CEO & Director | 1980 |
| Mr. Andrew R. Neill M.B.A. | Chief Financial Officer | 1986 |
| Dr. Arunthathy Nirmalini Pandite M.B.A., M.D. | Chief Medical Officer | 1959 |
| Mr. Brad Huckabee | Vice President of Accounting & SEC reporting | — |
| Dr. Abhinav A. Shukla Ph.D. | Chief Technical Officer | 1973 |
| Mr. Suresh de Silva Ph.D. | Chief Scientific Officer | — |
| Dr. Stephen Stout J.D., Ph.D. | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | 1975 |
| Ms. Casi DeYoung | Chief Business Officer | 1971 |
| Dr. Thomas Lampkin Pharm.D. | Senior Vice President of Regulatory Affairs | — |
| Ms. Kelli Collin M.B.A., M.S. | Senior Vice President of Quality | — |
Fundamentals
Valuation
Market cap$603.18M
Price-to-sales ratio587.10
Price-to-book value2.78
Price-earnings ratio-11.20
Return on Equity-61.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.47
Income Statement
Average volume784,894
EBITDA$-45.71M
1 year high (52w)$8.33
1 year low (52w)$1.70
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



